Tenaya Therapeutics Inc (TNYA)
4.78
+0.10
(+2.14%)
USD |
NASDAQ |
May 02, 12:56
Tenaya Therapeutics Shareholders Equity (Quarterly): 139.42M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 139.42M |
| September 30, 2023 | 164.88M |
| June 30, 2023 | 189.94M |
| March 31, 2023 | 215.41M |
| December 31, 2022 | 243.38M |
| September 30, 2022 | 196.33M |
| June 30, 2022 | 223.87M |
| Date | Value |
|---|---|
| March 31, 2022 | 249.10M |
| December 31, 2021 | 278.53M |
| September 30, 2021 | 303.70M |
| June 30, 2021 | -108.54M |
| March 31, 2021 | -93.94M |
| December 31, 2020 | -81.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-108.54M
Minimum
Jun 2021
303.70M
Maximum
Sep 2021
147.75M
Average
196.33M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Adverum Biotechnologies Inc | 83.47M |
| Solid Biosciences Inc | 126.48M |
| Dyne Therapeutics Inc | 91.29M |
| Sana Biotechnology Inc | 287.51M |
| Prime Medicine Inc | 133.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.52M |
| Total Liabilities (Quarterly) | 31.09M |